Important links
Twitter hashtag 鈥� #ProtDeg22
Synopsis
Targeted protein degradation is a rapidly developing field of drug discovery which is expanding the proportion of human proteins which are tractable drug targets. Whereas conventional small molecules are designed to block the activity of a protein, targeted protein degraders act by harnessing biological pathways to remove the protein entirely. This conference will showcase presentations showing the application and development of degradation technologies such as molecular glues and heterobifunctional degraders (e.g. PROTACs)
Who should attend
This conference is aimed at scientists including medicinal and computational chemists, structural and chemical biologists etc., and will be suitable for both those who are experienced in the field of targeted protein degradation and those who are keen to learn more about this rapidly developing field. This new conference is running in a virtual format, and we welcome an international audience of guests and speakers. The sessions are running in the afternoon UK time, and are therefore also easily accessible for a North and South American audience.
Call for Abstracts
Abstract submission is open now. Please click here to submit your oral abstract.
Organising Committee
Adrian Hall, UCB
Katherine Jones (chair), Charles River
Fabian Lecomte (treasurer), Ferring Pharmaceuticals
Twitter hashtag 鈥� #ProtDeg22
Synopsis
Targeted protein degradation is a rapidly developing field of drug discovery which is expanding the proportion of human proteins which are tractable drug targets. Whereas conventional small molecules are designed to block the activity of a protein, targeted protein degraders act by harnessing biological pathways to remove the protein entirely. This conference will showcase presentations showing the application and development of degradation technologies such as molecular glues and heterobifunctional degraders (e.g. PROTACs)
Who should attend
This conference is aimed at scientists including medicinal and computational chemists, structural and chemical biologists etc., and will be suitable for both those who are experienced in the field of targeted protein degradation and those who are keen to learn more about this rapidly developing field. This new conference is running in a virtual format, and we welcome an international audience of guests and speakers. The sessions are running in the afternoon UK time, and are therefore also easily accessible for a North and South American audience.
Call for Abstracts
Abstract submission is open now. Please click here to submit your oral abstract.
Organising Committee
Adrian Hall, UCB
Katherine Jones (chair), Charles River
Fabian Lecomte (treasurer), Ferring Pharmaceuticals
